齐鲁晚报.齐鲁壹点客户端李孟霏通讯员梁蓓蓓 在日月新半导体(威海)有限公司(以下简称"日月新")的万级无尘车间内，自动化设备高速运转，一个个 半导体元件随着流水线源源不断生产。 近年来，新能源汽车的爆发式增长为半导体元件行业带来了新机遇，日月新及时把握风口，布局新能源 领域，在国内国际市场上不断突破。但出口业务涉及政策复杂，要想赢得市场信任、持续提升竞争优 势，必须要把握好税务合规这一关键要素。 "政策享受不规范不仅会增加涉税风险，还增加税费成本。"日月新的财务人员表示，"税务部门的辅导 让我们对政策有了更清晰的认识，我们还惊喜地发现，准确适用政策后，每年还可减少相关税费成本近 350万。" 据悉，对于日月新在加工生产过程中产生的边角余料及废聚乙烯包装盒，企业需要按海关2025年最新政 策要求将保税货物转为内销货物出区销售。然而，由于公司贸易方式主要为来料、进料加工，所有料件 均为进口、货物及余料全部出口，且属于综合保税区特殊区域内企业，也未申请保税区一般纳税人试 点，无法享受"免、抵、退"税政策。对于内销边角料件业务，税收政策该如何适用？企业犯了难。与此 同时，企业仓库还积压了满满废料亟待销售，解决政策疑难 ...

证券日报网讯捷捷微电（300623）8月29日在互动平台回答投资者提问时表示，截至2025年8月20日，公 司股东总户数97063户(不含信用账户)。 ...

Core Viewpoint - Suzhou Goodwill (002079.SZ) reported a significant decline in revenue for the first half of 2025, while net profit showed substantial growth year-on-year, indicating a mixed financial performance [1] Financial Performance - The company achieved operating revenue of 1.993 billion yuan, a year-on-year decrease of 28.22% [1] - Net profit attributable to shareholders reached 43.7021 million yuan, reflecting a year-on-year increase of 310.28% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 14.074 million yuan, which represents a year-on-year decrease of 53.67% [1] - Basic earnings per share were reported at 0.0539 yuan [1]

捷捷微电公告，2025年上半年营业收入16亿元，同比增长26.77%。净利润2.47亿元，同比增长15.35%。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 ...

Group 1 - Industrial Fulian's market capitalization reached 462.3 billion, while Lens Technology surged by 11.4%, indicating a collective rise among major consumer electronics stocks [1] - Foxconn Technology Group has requested hundreds of Chinese engineers and technicians to leave its iPhone factory in India, impacting Apple's production expansion efforts in the region [2][3] - Despite Foxconn and Apple expressing optimism about manufacturing in India, challenges such as poor business environment and frequent power outages may hinder further investment in the country [3][4] Group 2 - The PCB, semiconductor components, and consumer electronics sectors experienced significant gains, reflecting market optimism [6][7] - The innovative drug sector is gaining attention, with potential for a major upward trend as new leaders emerge in the market [7] - Trading conditions remain challenging for short-term investors, despite overall market gains, with many facing difficulties in achieving profits [8]